Appointments at Inspire, King, Bionor and Oncothyreon – People on the move

By Nick Taylor

- Last updated on GMT

Related tags Corporate governance Johnson & johnson

in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Inspire, King, Bionor and Oncothyreon.

Robert Savel ​has been hired by Inspire Pharmaceuticals ​as SVP and chief technical officer. Savel will be responsible for all manufacturing and technical operations. Before joining Inspire, Savel worked at PDL Biopharma and Johnson & Johnson.

King Pharmaceuticals ​has named Jeffrey Bailey ​as chief commercial officer. Bailey has previously worked at Novartis, Janssen Pharmaceutica and Johnson & Johnson.

Henrik Lund ​has joined Bionor Pharma ​as CEO, replacing Trond Syvertsen​. Lund joins from AstraZeneca where he was responsible for clinical development activities in Europe, Asia and Latin America.

Oncothyreon ​has appointed Julie Eastland ​as chief financial officer and vice president (VP), corporate development. Eastland has previously worked at VLST, Dendreon and Amgen.

Stephen Stamp ​has been named as an independent non-executive director to the EUSA Pharma​ board. Stamp has experience of the speciality pharma sector from his time at Xanodyne Pharmaceuticals, Shire Pharmaceuticals and KV Pharmaceuticals.

Novasep ​has named Bernard Dubois ​as chairman of its supervisory board, replacing Pietro Stefanutti​. Dubois is the former SVP, head of global industrial operations at Aventis and has also worked as CEO of Cooper.

John-Michel Huss ​has been appointed as president and CEO of Theratechnologies​. Huss has more than 20 years of pharma experience working at companies including Merck & Co and Sanofi-Aventis.

The UK BioIndustry Association ​(BIA​) has elected Tim Edwards ​as chairman. Edwards succeeds Clive Dix ​who is stepping down after two years in the post. Currently Edwards is CEO of Cellzome and has also worked at British Biotech.

Related topics Markets & Regulations

Related news

Show more

Follow us


View more